The occurrence and development of diseases are usually related to abnormal intracellular signaling networks. The use of drugs to target and regulate the corresponding key molecules or functional pathways to intervene is an essential means of basic research and clinical treatment. Compared with traditional small molecule drugs, macromolecular drugs (such as proteins, antibodies, nucleic acids, etc.) have almost no restrictions on the types of target molecules recognized and have unique advantages in target specificity and drug efficacy. And this makes it one of the most promising and competitive fields of drug development. At present, the main targets of bio macromolecular drugs are located in the cell membrane or outside the cell because the selective permeability of the cell membrane prevents the drug from reaching the target position inside the cell smoothly. However, most of the potential targets of drugs are located inside cells, which also makes how to effectively deliver biomacromolecule drugs into cells a research hotspot in cancer treatment.
Cell-penetrating peptides (CPPs) can mediate the entry of biological macromolecules into cells and have become excellent materials for drug delivery due to their high biocompatibility and non-toxicity. However, CPPs still have defects such as low drug delivery efficiency and poor tolerance in serum, so it is essential to improve and optimize CPPs. Recently, researchers found that targeting negatively charged cancer cell surfaces with positively charged cell-penetrating peptides can effectively solve drug delivery problems. The drug can smoothly pass through the blood-brain barrier and target cancer cells by optimizing a positively charged TAT oligomer. This TAT polymer is a universal delivery system that can achieve the intervention and function regulation of the corresponding intracellular target only by combining with different functional proteins to achieve the purpose of treating related diseases. Therefore, this technology only provides a new strategy for the intracellular delivery of biological macromolecules and shows great potential in cancer therapy.
Profacgen is a state-of-the-art protein service provider. We provide custom protein services in the biological sciences, enabling access to the latest tools, techniques, and expertise with competitive pricing and rapid turnaround time. We serve a broad spectrum of industrial and academic clients committed to delivering high-quality data and customer services.
Please do not hesitate to contact us for more details if you are interested in this new method, and we will provide a considerate service for you. At the same time, we also offer other services and biomarker products; please move to our website for more details.
Reference
Fill out this form and one of our experts will respond to you within one business day.